期刊文献+

穿透性角膜移植术后角膜植片内皮慢性失功的临床分析 被引量:4

The analysis of chronic corneal allograft endothelial dysfunction after penetrating keratoplasty
原文传递
导出
摘要 目的探讨圆锥角膜行穿透性角膜移植(PK)术后角膜植片内皮慢性失功的临床特点。设计回顾性病例系列。研究对象圆锥角膜患者PK术后角膜植片内皮慢性失功148例(163眼)。方法所有患者实施PK术,采用非接触式角膜内皮显微镜、A型超声测厚仪和眼前节OCT扫描系统对角膜植片进行评价。主要指标中央角膜内皮细胞密度(ECD)、六边形细胞百分率、内皮细胞丢失率、内皮细胞形态、中央角膜厚度(CCT)及最佳矫正视力。结果PK术后3年内患者植片ECD呈下降趋势,内皮细胞年丢失率为14.2%±10.9%。术后1.5年较术后1年的ECD有明显下降(P=0.002)。术后不同时间点的植片内皮六边形细胞百分率均在50%以上,CCT在500μm以上,各组间比较无统计学差异(P=0.869)。PK术后5年以上复查,患者角膜植片ECD仍呈下降趋势,但个体差异性较大,多数患者的六边形细胞百分率仍在50%以上,内皮细胞面积增大是局部性的,CCT保持在500μm以上。150例未发生排斥的角膜植片除2例发生植片混浊外,其余均保持透明,患者术后最佳矫正视力提高。结论ECD的超生理下降和局部内皮细胞面积增大是PK术后角膜植片内皮慢性失功的主要临床表现。内皮慢性失功的发展存在个体差异性,且在同一个体不同时期发展程度亦有不同。 Objective To explore the clinical characteristics of chronic corneal allograft endothelial dysfunction after penetrating keratoplasty (PK) for keratoconus. Design Retrospective case series. Partidpants 148 cases (163 eyes) of keratoconus with chronic corneal allograft endothelial dysfunction after PK. Methods All cases treated with PK were analyzed by non-contact specular microscope, ultrasound corneal pachymetry and optical coherence tomography system. Main Outcome Measures Central corneal endothelial cell density (ECD), percentage of hexagonal cells, the rate of endothelial cell loss, morphologic changes of endothelial cell, central corneal thickness (CCT) and best corrected visual acuity (BCVA). Results ECD was decreased during three years after PK. The annual rate of endothelial cell loss was 14.2%+10.9%. The difference of ECD was significant between 1 year and 1.5 years after PK (P=0.002). At different time of three years after PK, percentages of hexagonal cells were above 50% and CCTs were above 500μm with no significant difference(P=0.869 ). ECD appeared decreasing above five years after PK, but there were much significances between different patients. In majority of those patients, percentages of hexagonal cells were above 50%, enlargement of area of endothelial cell were local,and CCTs were still above 500 μm. In 150 grafts without immunologic rejection, 2 grafts become opaque, but others remain transparent and BCVA enhanced. Conclusions Ultra-physiological descent of ECD and enlargement of area of endothelial cell are main clinical manifestations of chronic corneal allograft endothelial dysfunction after PK. There are individual differences during the development of chronic allograft endothelial dysfunction. Different extent of dysfunction exists in same individual at different time.
出处 《眼科》 CAS 2009年第3期169-174,共6页 Ophthalmology in China
关键词 慢性移植物失功 穿透性角膜移植 内皮 chronic allograft dysfunction penetrating keratoplasty endothelium
  • 相关文献

参考文献21

  • 1Kouwenhoven EA,IJzermans JN,de Bruin RW.Etiology and pathophysiology of chronic transplant dysfunction.Transpl Int,2000,13:385-401.
  • 2Nankivell BJ,Borrows BJ,Fung CL,et al.The natural history of chronic allograft nephropathy.N Engl J Med,2003,349:2326-2333.
  • 3Desai M,Neuberger J.Chronic liver allograft dysfunction.Transplant Proc,2009,41:773-776.
  • 4宫华青,高华,谢立信,史伟云.穿透性角膜移植术后慢性失功移植片的超微结构观察[J].中华眼科杂志,2007,43(4):307-312. 被引量:14
  • 5Rabinowitz YS.Keratoconus Surv Ophthalmol,1998,42:297-319.
  • 6史伟云,王旭,谢立信.穿透性角膜移植术后内皮型免疫排斥反应的临床研究[J].中华眼科杂志,2005,41(2):145-149. 被引量:22
  • 7Bourne WM,Nelson LR,Hodge DO.Central corneal endothelial cell changes over a ten-year period.Invest Ophthalmol Vis Sci,1997,38:779-782.
  • 8Müller-Pedersen TA.Comparative study of human corneal keratocyte and endothelial cell density during aging.Cornea,1997,16:333-338.
  • 9Bourne WM.Morphologic and functional evaluation of the endothelium of transplanted human corneas.Trans Am Ophthalmol Soc,1983,81:403-450.
  • 10Bourne WM,Hodge DO,Nelson LR.Corneal endothelium five years after transplantation.Am J Ophthalmol,1994,118:185-196.

二级参考文献19

  • 1谢立信 袁南勇 等.正常人角膜内皮细胞的内皮显微镜观察[J].中华眼科杂志,1985,21:354-357.
  • 2谢立信 康凤英 董晓光 等.穿透性角膜移植术后植片内皮细胞变化的动态观察[J].中华眼科杂志,1988,24:76-78.
  • 3Niederkorn JY. Mechanisms of corneal graft rejection.Cornea,2001,20:675-679.
  • 4Chang SD, Pecego JG, Zadnik K,et al. Factors influencing graft clarity. Cornea, 1996, 15:577-581.
  • 5Sonda Y, Sano Y, Brouce K, et al. Characterization of cell-mediated immune response elicited by orthotopic corneal allografts in mice. Invest Ophthaolmal Vis Sci,1995,36:427-434.
  • 6Niederkorn JY. The immune privilege of corneal allografts. Transplantation,1999, 67:1503-1508.
  • 7Yamagami S, Tsuru J, Tsobe N, et al. The role of cell adhesion in allograft rejection after penetrating keratoplasty in mice. Clinical and immunohistochemical study. Grafes Arch Clin Exp Ophthalmol,1996, 234:382.
  • 8Larkin DFP. Cornea allograft rejection. Br J Ophthalmol,1994, 78:649.
  • 9Price MO, Thompson RW Jr, Price FW Jr. Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol, 2003,121 : 1087-1092.
  • 10Furness PN. Histopathology of chronic renal allograft dysfunction.Transplantation, 2001,71:S31-36.

共引文献33

同被引文献26

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部